(E75.0) Gm 2 gangliosidosis

More details coming soon

Icon
59 638 in individuals diagnosis gm 2 gangliosidosis confirmed
Icon
10 673 deaths with diagnosis gm 2 gangliosidosis
Icon
18% mortality rate associated with the disease gm 2 gangliosidosis

Diagnosis gm 2 gangliosidosis is diagnosed Men are 26.00% more likely than Women

37 571

Men receive the diagnosis gm 2 gangliosidosis

5 833 (15.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
22 067

Women receive the diagnosis gm 2 gangliosidosis

4 840 (21.9 %)

Died from this diagnosis.

Risk Group for the Disease gm 2 gangliosidosis - Men and Women aged 5-9

Icon
In Men diagnosis is most often set at age 0-79
Icon
Less common in men the disease occurs at Age 80-95+Less common in women the disease occurs at Age 70-95+
Icon
In Women diagnosis is most often set at age 0-69

Disease Features gm 2 gangliosidosis

Icon
Absence or low individual and public risk
Icon

Gm 2 gangliosidosis - what does this mean

Gm 2 gangliosidosis is caused by a deficiency of an enzyme called beta-hexosaminidase, which leads to the accumulation of gm2 ganglioside in the cells of the body. this accumulation leads to the destruction of nerve cells in the brain and other organs, resulting in progressive mental and physical disability.

What happens during the disease - gm 2 gangliosidosis

Gm 2 gangliosidosis is a genetic disorder caused by a deficiency of the enzyme beta-hexosaminidase a, resulting in the accumulation of gm2 ganglioside in cells throughout the body. this accumulation leads to progressive damage to the nervous system, including the brain and spinal cord, resulting in neurological symptoms such as muscle weakness, seizures, and cognitive impairment.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Neurological assessment
  • CT scan
  • MRI scan
  • Genetic testing
  • Urine analysis
  • Blood tests
  • Lumbar puncture
  • Electroencephalogram (EEG)

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms and slow the progression of GM 2 gangliosidosis.
  • Prescribe drugs to reduce the accumulation of toxic substances in the body.
  • Provide physical therapy to help maintain muscle strength and flexibility.
  • Provide speech therapy to help improve communication skills.
  • Prescribe medications to reduce seizures.
  • Provide nutritional counseling to ensure the patient is getting the right nutrients.
  • Provide psychological counseling to help the patient and family cope with the diagnosis.
  • Provide genetic counseling to help the patient and family understand the condition.
Icon
30 Days of Hospitalization Required
Icon
203 Hours Required for Outpatient Treatment

Gm 2 gangliosidosis - Prevention

Gm 2 gangliosidosis can be prevented through genetic counselling and screening for carriers of the mutated gene, as well as prenatal testing for those at risk of having a child with the condition.